- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
International sales propel Imatron to fourth straight profitable quarter
Firm takes over some distribution from Siemens The good times continue to roll at ultrafast CT developer Imatron.The South San Francisco, CA, company last month announced itsfourth consecutive profitable quarter, with record revenues andan
Firm takes over some distribution from Siemens
The good times continue to roll at ultrafast CT developer Imatron.The South San Francisco, CA, company last month announced itsfourth consecutive profitable quarter, with record revenues andan $800,000 improvement in earnings over the same period lastyear.
Imatron has enjoyed growing demand this year for its ultrafastCT technology after sluggish years in 1992 and 1993. Several recentlyreleased studies have supported the clinical utility of its technologyin detecting early stages of coronary artery disease in asymptomaticpatients (SCAN 9/14/94).
The Pacific Rim in particular has been a hot spot for Imatron.The company last month landed a $4.5 million contract from Thailandand a $2.5 million order from Taiwan for C-150 scanners.
Imatron's revenues for the third quarter (end-September) were$8.9 million, a company record that reflected the shipment offive C-150 systems. The figure is 4% higher than the $8.6 millionposted in the third quarter of 1993. The numbers do not includerevenue from the Thailand and Taiwan sales, which will registerin the company's fourth quarter.
Imatron's earnings present an even rosier picture. The companyhad net income for the quarter of $582,000, compared to a lossof $223,000 in the same period last year. The firm's operatingprofit was $711,000.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
